与抗生素耐药性的消耗战：目前的策略旨在遏制抗生素耐药性，并进一步鼓励研究生产真正新颖的抗菌药物。
A war of attrition against antibiotic resistance: Current strategies try to keep antibiotic resistance at bay and further encourage research to produce genuinely novel antibacterials.
机构信息
Philip Hunter is a freelance journalist, London, UK.
出版信息
EMBO Rep. 2020 Jun 4;21(6):e50807. doi: 10.15252/embr.202050807. Epub 2020 May 24.
Abstract
To fight antibiotic resistance, novel drugs are urgently needed. Regulatory agencies are addressing the economic problems and offer new incentives for developing new antibiotics.
摘要
为了对抗抗生素耐药性，我们急需新型药物。监管机构正在解决经济问题，并为开发新型抗生素提供新的激励措施。
相似文献
1
A war of attrition against antibiotic resistance: Current strategies try to keep antibiotic resistance at bay and further encourage research to produce genuinely novel antibacterials.与抗生素耐药性的消耗战：目前的策略旨在遏制抗生素耐药性，并进一步鼓励研究生产真正新颖的抗菌药物。
EMBO Rep. 2020 Jun 4;21(6):e50807. doi: 10.15252/embr.202050807. Epub 2020 May 24.
2
Antibiotic resistance--action to promote new technologies: report of an EU Intergovernmental Conference held in Birmingham, UK, 12-13 December 2005.抗生素耐药性——促进新技术的行动：2005年12月12日至13日在英国伯明翰举行的欧盟政府间会议报告
J Antimicrob Chemother. 2006 Sep;58 Suppl 1:i3-i22. doi: 10.1093/jac/dkl373. Epub 2006 Sep 26.
3
Industry incentives and antibiotic resistance: an introduction to the antibiotic susceptibility bonus.产业激励与抗生素耐药性：抗生素药敏奖金介绍。
J Antibiot (Tokyo). 2020 Jul;73(7):421-428. doi: 10.1038/s41429-020-0300-y. Epub 2020 Mar 19.
4
Call for next-generation drugs that remove the uptake barrier to combat antibiotic resistance.呼吁研发新一代药物以消除摄取障碍，从而对抗抗生素耐药性。
Drug Discov Today. 2023 Oct;28(10):103753. doi: 10.1016/j.drudis.2023.103753. Epub 2023 Aug 26.
5
Microbial resistance to drug therapy: a review.微生物对药物治疗的耐药性：综述
Am J Infect Control. 1997 Feb;25(1):51-64. doi: 10.1016/s0196-6553(97)90054-7.
6
Screening for novel antibiotic resistance genes.新型抗生素抗性基因的筛选。
Methods Mol Biol. 2010;668:265-71. doi: 10.1007/978-1-60761-823-2_18.
7
The millennium bugs--the need for and development of new antibacterials.千年虫——新型抗菌药物的需求与研发
Int J Antimicrob Agents. 2000 Sep;16(1):51-9. doi: 10.1016/s0924-8579(00)00189-8.
8
Pharmacogenomic strategies against microbial resistance: from bright to bleak to innovative.对抗微生物耐药性的药物基因组学策略：从光明到黯淡再到创新。
Pharmacogenomics. 2010 Sep;11(9):1193-6. doi: 10.2217/pgs.10.18.
9
The effect of spatiotemporal antibiotic inhomogeneities on the evolution of resistance.时空抗生素不均匀性对耐药性演变的影响。
J Theor Biol. 2020 Feb 7;486:110077. doi: 10.1016/j.jtbi.2019.110077. Epub 2019 Nov 9.
10
The ADEP Biosynthetic Gene Cluster in Streptomyces hawaiiensis NRRL 15010 Reveals an Accessory Gene as a Novel Antibiotic Resistance Factor.链霉菌属中 ADEP 生物合成基因簇揭示了一个附加基因作为新型抗生素抗性因子。
Appl Environ Microbiol. 2019 Oct 1;85(20). doi: 10.1128/AEM.01292-19. Print 2019 Oct 15.
引用本文的文献
1
Multifunctional Properties of BMAP-18 and Its Aliphatic Analog against Drug-Resistant Bacteria.BMAP-18及其脂肪族类似物对耐药菌的多功能特性
Pharmaceuticals (Basel). 2023 Sep 25;16(10):1356. doi: 10.3390/ph16101356.
2
Cyanobacteria and Eukaryotic Microalgae as Emerging Sources of Antibacterial Peptides.蓝藻和真核微藻作为新兴的抗菌肽来源。
Molecules. 2020 Dec 9;25(24):5804. doi: 10.3390/molecules25245804.
3
Antibiotic Resistance: Moving From Individual Health Norms to Social Norms in One Health and Global Health.抗生素耐药性：在“同一健康”和全球健康背景下从个体健康规范迈向社会规范
Front Microbiol. 2020 Aug 28;11:1914. doi: 10.3389/fmicb.2020.01914. eCollection 2020.
本文引用的文献
1
The Science of Antibiotic Discovery.抗生素发现的科学。
Cell. 2020 Apr 2;181(1):29-45. doi: 10.1016/j.cell.2020.02.056. Epub 2020 Mar 19.
2
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
3
Non-traditional Antibacterial Therapeutic Options and Challenges.非传统抗菌治疗选择与挑战。
Cell Host Microbe. 2019 Jul 10;26(1):61-72. doi: 10.1016/j.chom.2019.06.004.
4
Eravacycline, a newly approved fluorocycline.依拉环素，一种新批准的氟环素。
Eur J Clin Microbiol Infect Dis. 2019 Oct;38(10):1787-1794. doi: 10.1007/s10096-019-03590-3. Epub 2019 Jun 7.
5
Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics-A Novel Way to Combat Antibiotic Resistance?先天免疫系统抗菌肽与传统抗生素联合应用——一种应对抗生素耐药性的新方法？
Front Cell Infect Microbiol. 2019 Apr 30;9:128. doi: 10.3389/fcimb.2019.00128. eCollection 2019.
6
The Super-Donor Phenomenon in Fecal Microbiota Transplantation.粪便微生物移植中的超级供体现象。
Front Cell Infect Microbiol. 2019 Jan 21;9:2. doi: 10.3389/fcimb.2019.00002. eCollection 2019.
7
The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.革兰氏阴性菌中由外排介导的抗生素耐药性挑战。
Clin Microbiol Rev. 2015 Apr;28(2):337-418. doi: 10.1128/CMR.00117-14.
8
Bacteriocins - a viable alternative to antibiotics?细菌素——抗生素的可行替代品？
Nat Rev Microbiol. 2013 Feb;11(2):95-105. doi: 10.1038/nrmicro2937. Epub 2012 Dec 24.
9
Potential of old-generation antibiotics to address current need for new antibiotics.老一代抗生素满足当前新型抗生素需求的潜力。
Expert Rev Anti Infect Ther. 2008 Oct;6(5):593-600. doi: 10.1586/14787210.6.5.593.
Zotero 插件